Multicenter Observational Study of Fulvestrant 500 mg in Postmenopausal Japanese Women with Estrogen Receptor-Positive Advanced or Recurrent Breast Cancer after Prior Endocrine Treatment (SBCCSG29 Study)

Kei Kimizuka; Kenichi Inoue; Shigenori E. Nagai; Tsuyoshi Saito; Satoko Nakano; Kazushige Futsuhara; Hirofumi Yamada; Shiori Kaneko; Takashi Sakurai; Satoshi Hata; Masafumi Kurosumi

doi:10.1272/jnms.jnms.2019_86-305

Multicenter Observational Study of Fulvestrant 500 mg in Postmenopausal Japanese Women with Estrogen Receptor-Positive Advanced or Recurrent Breast Cancer after Prior Endocrine Treatment (SBCCSG29 Study)

Journal of Nippon Medical School ◽

10.1272/jnms.jnms.2019_86-305 ◽

2019 ◽

Vol 86 (3) ◽

pp. 165-171 ◽

Cited By ~ 1

Author(s):

Kei Kimizuka ◽

Kenichi Inoue ◽

Shigenori E. Nagai ◽

Tsuyoshi Saito ◽

Satoko Nakano ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Observational Study ◽

Recurrent Breast Cancer ◽

Japanese Women ◽

Endocrine Treatment ◽

Multicenter Observational Study ◽

Estrogen Receptor Positive ◽

Recurrent Breast

Download Full-text

57PD Multicenter observational study of fulvestrant 500 mg in postmenopausal Japanese women with ER positive advanced or recurrent breast cancer after prior endocrine treatment (SBCCSG29 study)

Annals of Oncology ◽

10.1093/annonc/mdv519.06 ◽

2015 ◽

Vol 26 ◽

pp. ix16

Author(s):

K. Kimizuka ◽

K. Inoue ◽

S. Nagai ◽

T. Saito ◽

S. Nakano ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Recurrent Breast Cancer ◽

Japanese Women ◽

Endocrine Treatment ◽

Multicenter Observational Study ◽

Er Positive ◽

Recurrent Breast

Download Full-text

Abstract 1611: 4-protein signature predicts outcome to tamoxifen treatment in estrogen receptor positive recurrent breast cancer

10.1158/1538-7445.am2014-1611 ◽

2014 ◽

Author(s):

Tommaso De Marchi ◽

NingQing Liu ◽

Mila Tjoa ◽

Christoph Stingl ◽

Marcel Smid ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrent Breast Cancer ◽

Tamoxifen Treatment ◽

Estrogen Receptor Positive ◽

Recurrent Breast ◽

Positive Recurrent ◽

Protein Signature

Download Full-text

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer

Oncotarget ◽

10.18632/oncotarget.6521 ◽

2015 ◽

Vol 7 (3) ◽

pp. 3098-3110 ◽

Cited By ~ 8

Author(s):

Tommaso De Marchi ◽

Anne M. Timmermans ◽

Marcel Smid ◽

Maxime P. Look ◽

Christoph Stingl ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrent Breast Cancer ◽

Annexin A1 ◽

Estrogen Receptor Positive ◽

Recurrent Breast ◽

Positive Recurrent

Download Full-text

Paclitaxel as a first-line chemotherapy for Japanese women with advanced or recurrent breast cancer: a multi-institutional practice-based study by the Kyushu Breast Cancer Study Group (KBC-SG)

Breast Cancer ◽

10.1007/s12282-009-0118-8 ◽

2009 ◽

Vol 17 (2) ◽

pp. 131-135

Author(s):

Mikimasa Ishikawa ◽

Yasushi Takamatsu ◽

Shoshu Mitsuyama ◽

Nobutaka Iwakuma ◽

Keisei Anan ◽

...

Keyword(s):

Breast Cancer ◽

Recurrent Breast Cancer ◽

Japanese Women ◽

Study Group ◽

First Line ◽

Institutional Practice ◽

Cancer Study Group ◽

Breast Cancer Study ◽

Recurrent Breast ◽

Line Chemotherapy

Download Full-text

P4-10-11: Genetic and Environmental Predictors, Endogenous Hormones and Growth Factors and Risk of Estrogen Receptor-Positive Breast Cancer in Japanese Women.

10.1158/0008-5472.sabcs11-p4-10-11 ◽

2011 ◽

Author(s):

N Yoshimoto ◽

T Nishiyama ◽

T Toyama ◽

S Takahashi ◽

N Shiraki ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factors ◽

Japanese Women ◽

Endogenous Hormones ◽

Environmental Predictors ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Phosphatidyl-inositol-3-kinase Alpha catalytic subunit kinase domain mutations impart a favorable prognosis on estrogen receptor positive breast cancer through a mechanism that is independent of responsiveness to endocrine treatment.

10.1158/0008-5472.sabcs-6060 ◽

2009 ◽

Cited By ~ 1

Author(s):

MJ Ellis ◽

L Lin ◽

R Crowder ◽

Y Tao ◽

DB Evans ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Phosphatidyl Inositol ◽

Kinase Domain ◽

Catalytic Subunit ◽

Endocrine Treatment ◽

Favorable Prognosis ◽

Estrogen Receptor Positive ◽

Kinase Domain Mutations ◽

Positive Breast Cancer

Download Full-text

Abstract OT1-01-05: Endocrine treatment alone as primary treatment for elderly patients with estrogen receptor positive good prognosis operable breast cancer: A single arm phase II, single institution study

10.1158/1538-7445.sabcs18-ot1-01-05 ◽

2019 ◽

Author(s):

R Aft ◽

M Cherian ◽

A Frith ◽

R Suresh ◽

K Glover-Collins ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Elderly Patients ◽

Phase Ii ◽

Primary Treatment ◽

Good Prognosis ◽

Operable Breast Cancer ◽

Endocrine Treatment ◽

Single Institution ◽

Estrogen Receptor Positive

Download Full-text

Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

BMC Cancer ◽

10.1186/s12885-018-4558-4 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 3

Author(s):

Elisabetta Venturelli ◽

Annalisa Orenti ◽

Aline S. C. Fabricio ◽

Giulia Garrone ◽

Roberto Agresti ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Observational Study ◽

Cancer Patients ◽

Prognostic Value ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive ◽

Postmenopausal Estrogen ◽

Positive Breast Cancer

Download Full-text

Postoperative chemo–endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor–positive stage II breast cancer

Breast Cancer Research and Treatment ◽

10.1023/a:1006221425652 ◽

1999 ◽

Vol 56 (2) ◽

pp. 111-122 ◽

Cited By ~ 8

Author(s):

Keizo Sugimachi ◽

Yoshihiko Maehara ◽

Kohei Akazawa ◽

Yasuo Nomura ◽

Kazuyuki Eida ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Mitomycin C ◽

Stage Ii ◽

Endocrine Treatment ◽

Estrogen Receptor Positive

Download Full-text

329 Tamoxifen in premenopausal patients with estrogen receptor (E.R.) positive/unknown recurrent breast cancer

Journal of Steroid Biochemistry ◽

10.1016/0022-4731(83)91829-0 ◽

1983 ◽

Vol 19 ◽

pp. 110

Author(s):

A.H.G. Paterson

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrent Breast Cancer ◽

Premenopausal Patients ◽

Recurrent Breast

Download Full-text